Click image to view original image
Data of LGD-4033 (ligandrol) Powder:
IUPAC-Name:4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile
CAS: 1165910-22-4
Solubility: Propylene Glycol, DMSO, Ethanol
Molar Mass: 338.25 g/mol
Chemical Formula: C14H12F6N2O
Storage: Room temperature
Melting point: 105 - 106 °C
Organoleptic Profile: White fine powder, odorless, tasteless
Physical Form: Solid, powder
What is LIGANDROL(LGD-4033)?
LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It’s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.
How it works?
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers.
Dosages and Suggestion
Recommended maximum dose LIGANDROL the safety and tolerability up to doses of 22 mg -25mg . It has a half-life of 24 hours a day.
roy24ycgc@chembj.com
Whatsapp:+8618164087541
